Ascentage Pharma Group International (AAPG) Cash & Equivalents: 2022-2024
Historic Cash & Equivalents for Ascentage Pharma Group International (AAPG) over the last 3 years, with Dec 2024 value amounting to $122.4 million.
- Ascentage Pharma Group International's Cash & Equivalents fell 15.13% to $122.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $122.4 million, marking a year-over-year decrease of 15.13%. This contributed to the annual value of $122.4 million for FY2024, which is 13.96% down from last year.
- According to the latest figures from FY2024, Ascentage Pharma Group International's Cash & Equivalents is $122.4 million, which was down 13.96% from $142.2 million recorded in FY2023.
- In the past 5 years, Ascentage Pharma Group International's Cash & Equivalents registered a high of $200.4 million during FY2022, and its lowest value of $122.4 million during FY2024.
- In the last 3 years, Ascentage Pharma Group International's Cash & Equivalents had a median value of $142.2 million in 2023 and averaged $155.0 million.
- Data for Ascentage Pharma Group International's Cash & Equivalents shows a maximum YoY fell of 29.04% (in 2023) over the last 5 years.
- Over the past 3 years, Ascentage Pharma Group International's Cash & Equivalents (Yearly) stood at $200.4 million in 2022, then dropped by 29.04% to $142.2 million in 2023, then decreased by 13.96% to $122.4 million in 2024.